A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 5, 2013, Pages 367-375

  Pal, Tuya ^a,b   Cragun, Deborah ^a,c   Lewis, Courtney ^a   Doty, Andrea ^a   Rodriguez, Maria ^a   Radford, Cristi ^a   Thompson, Zachary ^a   Kim, Jongphil ^a,b   Vadaparampil, Susan T ^a,b,c  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER GENETICS; CLINICAL PRACTICE; ECHOMAMMOGRAPHY; FEMALE; GENE MUTATION; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; NURSE PRACTITIONER; PHYSICIAN; PROFESSIONAL KNOWLEDGE; REVIEW; TUMOR SUPPRESSOR GENE;

ADULT; BRCA1 PROTEIN; BREAST NEOPLASMS; FEMALE; FLORIDA; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; OVARIAN NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS;

EID: 84876901187     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0381     Document Type: Review

References (44)

1. Albrecht TL, Ruckdeschel JC, Ray FL, 3rd et al. (2005) A portable, unobtrusive device for videorecording clinical interactions. Behav Res Methods 37:165-169.
2. American Board of Medical Genetics (2012) Members. Available at www.abmg.org/pages/searchmem.shtml, accessed June 15, 2012.
3. Antoniou A, Pharoah PD, Narod S, et al. (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117-1130.
4. Blazer KR, Macdonald DJ, Culver JO, et al. (2011) Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce. Genet Med 13:832-840.
5. Brierley KL, Campfield D, Ducaine W, et al. (2010) Errors in delivery of cancer genetics services: implications for practice. Conn Med 74:413-423.
6. Caleshu C, Day S, Rehm HL, et al. (2010) Use and interpretation of genetic tests in cardiovascular genetics. Heart 96:1669-1675.
7. Chan M, Mo Ji S, Yeo ZX, et al. (2012) Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform. J Mol Diagn 14:602-612.
8. Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329-1333.
9. Cohen SA, McIlvried D, Schnieders J (2009) A collaborative approach to genetic testing: a community hospital's experience. J Genet Couns 18:530-533.
10. Doksum T, Bernhardt BA, Holtzman NA (2003) Does knowledge about the genetics of breast cancer differ between non-geneticist physicians who do or do not discuss or order BRCA testing? Genet Med 5:99-105.
11. Domchek S, Weber BL (2008) Genetic variants of uncertain significance: flies in the ointment. J Clin Oncol 26:16-17.
12. Esserman L, Kaklamani V (2010) Lessons learned from genetic testing. JAMA 304:1011-1012.
13. Forum NCP, Medicine Io (2007) Cancer-Related Genetic Testing and Counseling: Workshop Proceedings. The National Academies Press. Washington, D.C.
14. Geier LJ, Mulvey TM, Weitzel JN (2009) Clinical Cancer Genetics Remains a Specialized Area: How Do I Get There From Here? American Society of Clinical Oncology. ASCO 2009 Educational Book: Practice Management and Information Technology.
15. Gynecologists ACoOa (2009) ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome. Obstet Gy-necol 113:957-966.
16. Hudson KL, Murphy JA, Kaufman DJ, et al. (2006) Oversight of US genetic testing laboratories. Nat Biotechnol 24:1083-1090.
17. Hull SC, Prasad K (2001) Reading between the lines: direct-to-consumer advertising of genetic testing in the USA. Reprod Health Matters 9:44-48.
18. Jaen CR, Stange KC, Nutting PA (1994) Competing demands of primary care: a model for the delivery of clinical preventive services. J Fam Pract 38:166-171.
19. Judkins T, Rosenthal E, Arnell C, et al. (2012) Clinical significance of large rearrangements in BRCA1 and BRCA2. Cancer 118:5210-5216.
20. Keating NL, Stoeckert KA, Regan MM, et al. (2008) Physicians' experiences with BRCA1/2 testing in community settings. J Clin Oncol 26:5789-5796.
21. Matloff E, Caplan A (2008) Direct to confusion: lessons learned from marketing BRCA testing. Am J Bioeth 8:5-8.
22. McPherson E, Zaleski C, Benishek K, et al. (2008) Clinical genetics provider real-time workflow study. Genet Med 10:699-706.
23. Myers MF, Chang MH, Jorgensen C, et al. (2006) Genetic testing for susceptibility to breast and ovarian cancer: evaluating the impact of a direct-to-consumer marketing campaign on physicians' knowledge and practices. Genet Med 8:361-370.
24. National Accreditation Program for Breast Centers (2012) Breast Center Standards Manual. Available at http://napbc-breast.org/standards/ 2012standardsmanual.pdf, accessed June 15.
25. National Comprehensive Cancer Network (2012) Genetic/Familial High-risk Assessment: Breast and Ovarian. Available at www.nccn.org/professionals/ physician-gls/recently-updated.asp, accessed July 10, 2012.
26. National Society of Genetic Counselors (2012) Find a Genetic Counselor. Available at www.nsgc.org/FindaGeneticCounselor/ FindAGeneticCounselorbyInformation/tabid/68/Default.aspx, accessed June 15.
27. Obdeijn IM, Loo CE, Rijnsburger AJ, et al. (2010) Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition. Breast Cancer Res Treat 119:399-407.
28. Pal T, Permuth-Wey J, Betts JA, et al. (2005) BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104:2807-2816.
29. Pal T, Radford C, Vadaparampil ST, et al. (accepted for publication) Practical Considerations in the delivery of genetic counseling and testing services for inherited cancer predisposition. Community Oncology.
30. Peterson SK, Rieger PT, Marani SK, et al. (2001) Oncology nurses' knowledge, practice, and educational needs regarding cancer genetics. Am J Med Genet 98:3-12.
31. Plon SE, Cooper HP, Parks B, et al. (2011) Genetic testing and cancer risk management recommendations by physicians for at-risk relatives. Genet Med 13:148-154.
32. Rantanen E, Hietala M, Kristoffersson U, et al. (2008) Regulations and practices of genetic counselling in 38 European countries: the perspective of national representatives. Eur J Hum Genet 16:1208-1216.
33. Riley BD, Culver JO, Skrzynia C, et al. (2012) Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. J Genet Couns 21:151-161.
34. Robson ME, Storm CD, Weitzel J, et al. (2010) American Society of Clinical Oncology policy statement update: genetic and ge-nomic testing for cancer susceptibility. J Clin Oncol 28:893-901.
35. Rosenthal ET (2007) Shortage of genetics counselors may be anecdotal, but need is real. Oncology Times 29:34, 36.
36. Shannon KM, Rodgers LH, Chan-Smutko G, et al. (2011) Which individuals undergoing BRAC analysis need BART testing? Cancer Genet 204:416-422.
37. Oncology Nursing Society (2009) Role of the Oncology Nurse in Cancer Genetic Counseling. Available at www.ons.org/Pub-lications/Positions/ GeneticCounseling/, accessed October 17.
38. Tung N (2011) Management of women with BRCA mutations: a 41-year-old woman with a BRCA mutation and a recent history of breast cancer. JAMA 305:2211-2220.
39. U.S. Department of Commerce 2010 United States Census. Available at www.census.gov/popest/data/state/totals/2011/index.html, accessed June 15.
40. U.S. Preventive Services Taskforce (2005) Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility. Available at www.uspreventiveservicestaskforce.org/uspstf/uspsbrgen.htm, accessed August 29, 2012.
41. Vadaparampil ST, Wideroff L, Olson L, et al. (2005) Physician exposure to and attitudes toward advertisements for genetic tests for inherited cancer susceptibility. Am J Med Genet A 135:41-46.
42. Veloski J, Tai S, Evans AS, et al. (2005) Clinical vignette-based surveys: a tool for assessing physician practice variation. Am J Med Qual 20:151-157.
43. Vig HS, Armstrong J, Egleston BL, et al. (2009) Cancer genetic risk assessment and referral patterns in primary care. Genet Test Mol Biomarkers 13:735-741.
44. Wideroff L, Vadaparampil ST, Greene MH, et al. (2005) Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet 42:749-755.